These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20456647)

  • 1. Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications.
    Borleffs CJ; Thijssen J; de Bie MK; van Rees JB; van Welsenes GH; van Erven L; Bax JJ; Cannegieter SC; Schalij MJ
    Pacing Clin Electrophysiol; 2010 Aug; 33(8):1013-9. PubMed ID: 20456647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database.
    Krahn AD; Lee DS; Birnie D; Healey JS; Crystal E; Dorian P; Simpson CS; Khaykin Y; Cameron D; Janmohamed A; Yee R; Austin PC; Chen Z; Hardy J; Tu JV;
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):136-42. PubMed ID: 21325209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry.
    Poole JE; Gleva MJ; Mela T; Chung MK; Uslan DZ; Borge R; Gottipaty V; Shinn T; Dan D; Feldman LA; Seide H; Winston SA; Gallagher JJ; Langberg JJ; Mitchell K; Holcomb R;
    Circulation; 2010 Oct; 122(16):1553-61. PubMed ID: 20921437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications associated with generator replacement in response to device advisories.
    Costea A; Rardon DP; Padanilam BJ; Fogel RI; Prystowsky EN
    J Cardiovasc Electrophysiol; 2008 Mar; 19(3):266-9. PubMed ID: 18081773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The innominate vein as alternative venous access for complicated implantable cardioverter defibrillator revisions.
    Aleksic I; Kottenberg-Assenmacher E; Kienbaum P; Szabo AK; Sommer SP; Wieneke H; Yildirim C; Leyh RG
    Pacing Clin Electrophysiol; 2007 Aug; 30(8):957-60. PubMed ID: 17669077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explantation of implantable defibrillator leads using open heart surgery or percutaneous techniques.
    Camboni D; Wollmann CG; Löher A; Gradaus R; Scheld HH; Schmid C
    Ann Thorac Surg; 2008 Jan; 85(1):50-5. PubMed ID: 18154777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erosion of an extrapericardial implantable cardioverter defibrillator patch through the gastric fundus with fistulous tract formation.
    Nathan S; Piccione W; Kumar A; Attanasio S; Schaer GL
    Cardiol Rev; 2006; 14(6):e21-3. PubMed ID: 17053368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter-defibrillator infection due to Scedosporium apiospermum.
    Sarvat B; Sarria JC
    J Infect; 2007 Oct; 55(4):e109-13. PubMed ID: 17761293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences.
    Nery PB; Fernandes R; Nair GM; Sumner GL; Ribas CS; Menon SM; Wang X; Krahn AD; Morillo CA; Connolly SJ; Healey JS
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):786-90. PubMed ID: 20102431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.
    Sohail MR; Uslan DZ; Khan AH; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Stoner S; Baddour LM
    J Am Coll Cardiol; 2007 May; 49(18):1851-9. PubMed ID: 17481444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillator: beyond efficacy.
    Timóteo AT; Adragão P; Morgado F; Abecassis M; Neves JP; Cavaco D; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 2001 Nov; 20(11):1071-85. PubMed ID: 11826698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices.
    Duray GZ; Schmitt J; Cicek-Hartvig S; Hohnloser SH; Israel CW
    Europace; 2009 Mar; 11(3):297-302. PubMed ID: 19054788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse interaction between a left ventricular assist device and an implantable cardioverter defibrillator.
    Matthews JC; Betley D; Morady F; Pelosi F
    J Cardiovasc Electrophysiol; 2007 Sep; 18(10):1107-8. PubMed ID: 17403078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes of redo procedures in patients with an implantable cardioverter-defibrillator--long-term follow-up results.
    Gepner K; Przybylski A; Maciag A; Sterliński M; Lewandowski M; Syska P; Kowalik I; Szwed H
    Kardiol Pol; 2007 Aug; 65(8):893-8; discussion 899. PubMed ID: 17853318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular oversensing after replacement of an implantable cardioverter-defibrillator.
    Arias MA; Puchol A; Castellanos E; Pachón M; Rodríguez-Padial L
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):925-7. PubMed ID: 19572871
    [No Abstract]   [Full Text] [Related]  

  • 17. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories.
    Gould PA; Krahn AD;
    JAMA; 2006 Apr; 295(16):1907-11. PubMed ID: 16639049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should recent defibrillator and lead advisories affect decisions to refer patients for implantable cardioverter-defibrillator therapy?
    Amin MS; Ellenbogen KA
    Curr Opin Cardiol; 2010 Jan; 25(1):23-8. PubMed ID: 19907318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia.
    Uslan DZ; Sohail MR; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Baddour LM
    Clin Infect Dis; 2006 Sep; 43(6):731-6. PubMed ID: 16912947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of device-related and lead-related complications in the dual-chamber implantable cardioverter defibrillator compared with the single-chamber version.
    Takahashi T; Bhandari AK; Watanuki M; Cannom DS; Sakurada H; Hiraoka M
    Circ J; 2002 Aug; 66(8):746-50. PubMed ID: 12197599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.